Murphy Pohlad Asset Management LLC Invests $458,000 in Teladoc Health, Inc. (NYSE:TDOC)

Murphy Pohlad Asset Management LLC acquired a new stake in Teladoc Health, Inc. (NYSE:TDOC) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 50,400 shares of the health services provider’s stock, valued at approximately $458,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in TDOC. Point72 Asset Management L.P. lifted its holdings in shares of Teladoc Health by 57.8% during the third quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock worth $76,803,000 after buying an additional 3,063,172 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Teladoc Health by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock valued at $36,042,000 after purchasing an additional 56,864 shares during the period. Assenagon Asset Management S.A. acquired a new stake in Teladoc Health in the 3rd quarter worth $15,801,000. Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Teladoc Health by 15.5% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider’s stock valued at $15,617,000 after buying an additional 228,004 shares during the period. Finally, Invenomic Capital Management LP grew its position in Teladoc Health by 155.2% during the third quarter. Invenomic Capital Management LP now owns 1,474,337 shares of the health services provider’s stock worth $13,534,000 after buying an additional 896,552 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Price Performance

Shares of NYSE TDOC opened at $10.38 on Thursday. Teladoc Health, Inc. has a 1-year low of $6.76 and a 1-year high of $21.74. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The company has a 50-day moving average of $10.09 and a two-hundred day moving average of $9.06.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.51 million during the quarter, compared to analysts’ expectations of $630.50 million. On average, equities research analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Carlos Nueno sold 2,389 shares of Teladoc Health stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the sale, the insider now directly owns 2,890 shares of the company’s stock, valued at $34,477.70. The trade was a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.95% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Barclays boosted their price objective on Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Evercore ISI raised their price objective on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Piper Sandler reissued an “overweight” rating and issued a $13.00 target price (up previously from $11.00) on shares of Teladoc Health in a research note on Wednesday, December 4th. The Goldman Sachs Group started coverage on shares of Teladoc Health in a research note on Friday, November 15th. They set a “buy” rating and a $14.00 price target for the company. Finally, TD Cowen dropped their target price on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, October 31st. Fourteen analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, Teladoc Health currently has a consensus rating of “Hold” and an average target price of $12.08.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.